Point-of-care continuous 13C-methacetin breath test improves decision making in acute liver disease: Results of a pilot clinical trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

346

HTML

3645

Figures (1-2)

244

Tables (1-5)

196

Sum=4431

Feb 28, 2009 (publication date) through Sep 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. Feb 28, 2009; 15(8): 966-972
Published online Feb 28, 2009. doi: 10.3748/wjg.15.966

Table 5 Blood tests versus breath test parameters (mean, SD)

	Point of stable improvement (days after treatment)	Convergence to normality (days after treatment)
Breath test	2.85, 2.23	8.89, 11.5
ALT	7.33, 11.06	28.24, 21.69
AST	7.62, 11.44	12.96, 6.96
INR	8.62, 12.1	16.02, 24.71
BIL	7, 10.61	23.63, 22.61

Citation: Lalazar G, Adar T, Ilan Y. Point-of-care continuous ¹³C-methacetin breath test improves decision making in acute liver disease: Results of a pilot clinical trial. World J Gastroenterol 2009; 15(8): 966-972
URL: https://www.wjgnet.com/1007-9327/full/v15/i8/966.htm
DOI: https://dx.doi.org/10.3748/wjg.15.966